welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!
Healthcare Providers

Basil Darras, MD

Healthcare Provider
Associate Neurologist-in-Chief
Boston Children's Hospital
Fegan 11 Neurology
300 Longwood Avenue, Fegan, 11th Floor
Boston, Massachusetts, United States

Dr. Darras serves as an expert in the Department of Neurology for Boston Children’s Hospital Precision Medicine Service. During his practice, he focuses on treating children with neuromuscular diseases, which present as problems of motor development and function. He is also an Associate neurologist-in-Chief at Boston Children’s Hospital and holds the Joseph J. Volpe Chair in Neurology at Harvard Medical School. At Boston Children’s Hospital, he directs the Neuromuscular Program, which provides diagnostic evaluation and therapeutic services for children with neuromuscular diseases and the Spinal Muscular Atrophy (SMA) Clinical Research Program, which seeks to improve medical care of children with SMA and discover new treatments for this devastating motor neuron disease.

Dr. Darras’s special focus is in the care of children with neuromuscular conditions originating from inherited or acquired conditions of the motor unit. Further, he sees patients with general neurological problems such as seizures when he attend on the inpatient neurology services. Through his clinical and research experience, as well as his hospital leadership roles, Dr. Darras has influenced care in the field of pediatric neuromuscular diseases both nationally and internationally.


Representative Publications:

A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial

Spectrum of Neuromuscular Disorders With HyperCKemia From a Tertiary Care Pediatric Neuromuscular Center

Electrical impedance myography for assessment of Duchenne muscular dystrophy

Quantitative muscle ultrasound detects disease progression in Duchenne muscular dystrophy

Developing standardized corticosteroid treatment for Duchenne muscular dystrophy